Browse studies

Find your next paid study

60 recruiting studies matching your filters

Imaging Immune Activation in HIV Infection

This is a single center exploratory imaging study involving one intravenous microdose of \[18F\]F-AraG followed by whole-body positron emission tomography-magn…

HIV Infections

Estimated

~$10 – $8,750

CellSight Technologies, Inc.NCT03684655

Observational

Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention (SEAL)

This randomized control trial study among Pre-exposure prophylactic users (PrEP) aims to learn and determine the efficacy of Screening, brief intervention, and…

Alcohol Use DisorderRisk Behavior, HealthDysbiosis+1 more

Estimated

~$10 – $7,500

Shirish S BarveNCT06005298

Observational

Evaluation of a Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Risky Alcohol Use Among Individuals Vulnerable to HIV/AIDS

Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking eve…

Risk BehaviorAlcohol Use DisorderHIV Infections

Estimated

~$10 – $6,250

University of KentuckyNCT05576350

Phase 4

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in indiv…

HIV InfectionsAge

Estimated

~$10 – $7,500

Hennepin Healthcare Research InstituteNCT06514547

Observational

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV p…

HIV InfectionsSexually Transmitted Diseases

Estimated

~$10 – $5,625

Public Health Foundation Enterprises, Inc.NCT04855773

Observational

Test-to-PrEP: A Randomized Hybrid Implementation/Effectiveness Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information

To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) comp…

HIV Infections

Estimated

~$10 – $6,250

University of MiamiNCT06927856

Observational

Feasibility and Preliminary Effectiveness of PrEPwise Intervention on PrEP Initiation Among Black Women in Eastern Virginia

HIV is a virus that affects many people, but Black women in the U.S. are a population at a much higher risk of getting it compared to white women-about 18 time…

HIV InfectionsSexually Transmitted Infection

Estimated

~$10 – $6,250

Boston UniversityNCT07398482

Observational

Teamwork Makes the Dream Work: Team-based Inpatient Anti-Retroviral Treatment and Access to Services (ARTAS)

Exploring the effect of team-based ARTAS intervention in an inpatient setting on HIV linkage to care and hospital readmission rates.

HIV InfectionsInpatient Facility Diagnoses

Estimated

~$10 – $6,250

Loma Linda UniversityNCT05866523

Observational

Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department

The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DP…

HIV InfectionsSyphilis Infection

Estimated

~$10 – $6,250

The University of Texas Health Science Center, HoustonNCT07525076

Phase 1

Phase 1/2 Study of Switching to Fixed Dose Combination Dolutegravir/Rilpivirine Among Virologically Suppressed Children, 6 to Less Than 12 Years of Age, Living With HIV-1

The purpose of this study is to provide data on the pharmacokinetic (PK), safety, tolerability, efficacy and acceptability of this fixed dose combination (FDC)…

HIV Infections

Estimated

~$10 – $7,500

ViiV HealthcareNCT05674656

Phase 1

A Phase I, Multi-centre, Open-label, Single Dose Escalation Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Long-acting Cabotegravir Co-administered With Recombinant Human Hyaluronidase PH20 (rHuPH20) in Healthy Adult Volunteers

This is an open-label, dose-escalation study to investigate the safety, tolerability and pharmacokinetics (PK) of single subcutaneous (SC) administration of lo…

HIV Infections

Estimated

~$10 – $7,500

ViiV HealthcareNCT05418868

Phase 1

A Phase 1 Double-Blind (Sponsor-unblinded), Placebo-Controlled, Randomized, Single Dose Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Parenterally Administered Long-acting Formulations of VH4011499 in Adults Without HIV

The purpose of this study is to investigate safety, pharmacokinetics and tolerability following single ascending dose (SAD) and multiple ascending doses (MAD) …

HIV Infections

Estimated

~$10 – $7,500

ViiV HealthcareNCT06724640